Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9062115 Therapeutic factor VIII antibodies

Patent 9062115 was granted and assigned to Novo Nordisk on June, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Henrik Oestergaard0

Kasper Lamberth0

Jes Thorn Clausen0

Heidi Lindgreen Holmberg0

Ida Hilden0

Date of Patent

June 23, 2015

0

Patent Application Number

138229520

Date Filed

September 15, 2011

0

Patent Citations Received

US Patent 11654193 Cancer treatment combinations

0

Patent Primary Examiner

Marianne P Allen

0

Patent abstract

The present invention relates to therapeutic FVIII antibodies. In particular, the present invention relates to FVIII antibodies having the ability to prolong the circulatory half life of FVIII. The present invention furthermore relates to use of such antibodies in treatment and prophylaxis of haemophilia A.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9062115 Therapeutic factor VIII antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.